FDA Approves Mounjaro for Heart Risk Reduction: Eli Lilly’s Mounjaro (tirzepatide) won FDA approval to cut heart attack and stroke risk in high-risk adults with type 2 diabetes, extending GLP-1 momentum beyond weight loss. Clinical Research Participation: A new report highlights how many Americans join clinical trials—often without fully understanding them—underscoring the need for clearer outreach and access. Public Health—Ebola Watch: Congo’s fast-growing Ebola outbreak is still out of control, with officials stressing the U.S. risk remains low due to strong infection control. Measles and Vaccine Access: Coverage notes measles activity in Pennsylvania and broader debates over vaccine exemptions, with health officials pushing for school-ready immunization. Rural Care Capacity: Multiple items point to pressure on rural hospitals and access gaps, including concerns about longer drives for obstetric care. Health Policy Funding: Title X family planning funding is in the spotlight as Nevada’s attorney general sues to protect reproductive health services. Healthcare Fraud and Oversight: Federal actions continue against fraudulent schemes, including Medicaid billing cases and hospital-related financial scrutiny. Immigration Enforcement and Health: Reports describe injuries and hospitalizations tied to ICE encounters, raising questions about enforcement practices and accountability. Medical Tech Regulation: The FDA seeks public input on regulating generative AI medical devices as healthcare adoption accelerates.